Accessed: 08.10.2019
Based on the National Guidelines for the Management of Tuberculosis in Children 2013, Department of Health, South Africa.
Morbidity and Mortality Weekly Report (MMWR) October 4, 2019 / 68(39);851–854
Editorial Review
AIDS 2019, 33:1411–1420
As an inter-faith network of religious leaders living with or affected by HIV, INERELA+ seeks to empower religious leaders through education, knowledge and skills to live positively, becoming symbols of hope and agents of change who will help eliminate stigma and discrimination within their congrega...tions and communities.
Accessed: 12.11.2019
more
Review
Drake AL et al. Journal of the International AIDS Society 2019, 22:e25271 http://onlinelibrary.wiley.com/doi/10.1002/jia2.25271/full | https://doi.org/10.1002/jia2.25271
All In #EndAdolescentAIDS
Global Webinar: Novel Approaches for Addressing Age of Consent as a Barrier to Adolescents' Care Utilization and Engagement
Accessed: 26.10.2019
Employees, Coworkers, and Supervisors
Accessed: 20.11.2019
The report shows that where people and communities living with and affected by HIV are engaged in decision-making and HIV service delivery, new infections decline and more people living with HIV gain access to treatment. When people have the power to choose, to know, to thrive, to demand and to work... together, lives are saved, injustices are prevented and dignity is restored.
more
Practical considerations
It provides more detailed and practical guidance for continuing services for each life stage across the life-course continuum. As such, both documents should be read and used together. The countries in South-East Asia and the Pacific regions would like to adapt the guidance... within the national and sub-national continuity plans, based on the local situation of COVID-19 transmission, containment response and health system capacity.
more
Malaria deaths, Malaria cases
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
The purpose of this document is to provide relevant information and guidelines on
coronavirus outbreaks – and in particular the novel coronavirus SARS-CoV-2 and the
diseases it produces, COVID-19 – for pharmacists and the pharmacy workforce, both in a
primary care context (i.e. community phar...macies and primary healthcare facilities) and in
hospital settings, as well as for pharmacists working as clinical biologists in medical
analysis laboratories, for example, as clinical biologists, and offer a set of references that
may be consulted for more informationstor
more